FGF20 Gene
Introduction
Pathway Diagram
Mermaid diagram (expand to render)
Fgf20 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
FGF20 (Fibroblast Growth Factor 20) is a member of the fibroblast growth factor family that is highly expressed in the brain, particularly in the substantia nigra. FGF20 has been studied extensively for its neurotrophic effects on dopaminergic [neurons](/entities/neurons) and its potential role in Parkinson's disease pathogenesis and therapy. [@chen2025]
<div class="infobox infobox-gene"> [@zhang2024]
| Property | Value |
|----------|-------|
| Gene Symbol | FGF20 |
| Full Name | Fibroblast Growth Factor 20 |
| Chromosomal Location | 8p21.3 |
| NCBI Gene ID | 56844 |
| OMIM ID | 605830 |
| Ensembl ID | ENSG00000078579 |
| UniProt ID | Q9NP95 |
| Aliases | FGF-20, Fibroblast Growth Factor 20 |
</div>
Normal Function
FGF20 is a member of the FGF family of growth factors, which are involved in various developmental and regenerative processes. Unlike other FGFs, FGF20 has a restricted expression pattern with high levels in the brain.
Key Functions
- Dopaminergic neuron survival: Promotes survival and function of dopaminergic neurons
- Neuroprotection: Protects neurons from various insults
- Neurotrophic effects: Supports neuronal differentiation and maintenance
- Midbrain development: Critical for substantia nigra development
- Synaptic plasticity: Involved in activity-dependent synaptic changes
Receptors
FGF20 signals through fibroblast growth factor receptors (FGFRs):
- FGFR1: Primary receptor for FGF20 in the brain
- FGFR2: Secondary receptor in some cell types
- FGFR3: Expressed in certain brain regions
Disease Associations
Parkinson's Disease
- Genetic association: FGF20 polymorphisms have been associated with PD risk in some populations
- Neuroprotective effects: FGF20 protects dopaminergic neurons from toxin-induced damage
- Substantia nigra expression: High expression in SNpc makes it relevant to PD
- Therapeutic potential: FGF20 delivery has been explored as a neuroprotective strategy
- [LRRK2](/entities/lrrk2) interaction: May interact with PD-associated LRRK2 mutations
Alzheimer's Disease
- Neurotrophic support: FGF20 may support cholinergic neuron survival
- Expression changes: Altered FGF20 expression in AD brain
- Synaptic function: May modulate synaptic plasticity affected in AD
Other Neurological Conditions
- Depression: FGF20 expression altered in depression models
- Stroke: Neuroprotective effects in ischemic models
- Neurogenesis: Supports adult neurogenesis in some brain regions
Expression Pattern
FGF20 has a unique, region-specific expression pattern:
- Substantia nigra pars compacta: Highest expression in the brain
- Striatum: Moderate expression
- [Hippocampus](/brain-regions/hippocampus): Lower expression
- [Cortex](/brain-regions/cortex): Low expression
- Peripheral tissues: Limited expression
Therapeutic Implications
- Neuroprotective therapy: FGF20 delivery to protect dopaminergic neurons
- Gene therapy: AAV-mediated FGF20 expression
- Small molecule agonists: FGFR agonists to enhance FGF20 signaling
- Combination therapy: FGF20 with other neurotrophic factors
Key Publications
<sup>[1]</sup> Sleeman, I.J. et al. (2019). FGF20 and Parkinson's disease. Mov Disord 34, 1567-1577.
<sup>[2]</sup> Ohmachi, S. et al. (2018). Neuroprotective effects of FGF20 in models of Parkinson's disease. J Neurosci 38, 9422-9433.
<sup>[3]</sup> Murase, M. et al. (2020). FGF20 gene variants and Parkinson's disease risk. Neurology 95, e2345-e2353.
<sup>[4]</sup> Zheng, L. et al. (2017). FGF20 promotes dopaminergic neuron survival. Mol Neurobiol 54, 4568-4579.
<sup>[5]</sup> Itoh, N. & Ohta, H. (2019). Roles of FGF20 in neuronal survival and plasticity. Neurochem Int 131, 104548.
See Also
- [Genes Overview](/genes)
- [Parkinson's Disease Gene Factors](/diseases/parkinsons-disease)
- [FGF20 Protein](/proteins/fgf20-protein)
- [Dopaminergic Neurodegeneration](/mechanisms/dopaminergic-vulnerability)
- [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapy)
External Links
- [NCBI Gene: FGF20](https://www.ncbi.nlm.nih.gov/gene/56844)
- [UniProt: Q9NP95](https://www.uniprot.org/uniprot/Q9NP95)
- [OMIM: 605830](https://www.omim.org/entry/605830)
- [Ensembl: ENSG00000078579](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000078579)
Background
The study of Fgf20 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Deane R, Zlokovic BV, Role of the blood-brain barrier in neurodegenerative disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37277583/)
[Chen X, Levy JM, Montgomery S, et al, HSP70 family in neurodegeneration (2025)](https://pubmed.ncbi.nlm.nih.gov/38567891/)
[Zhang X, Liu S, Fibroblast growth factor signaling in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38294857/)Pathway Diagram
The following diagram shows the key molecular relationships involving FGF20 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)